Issuu on Google+

The Peer-Reviewed Forum for Evidence in Benefit Design ™ March/April 2013 Volume 6, Number 2 For Payers, Purchasers, Policymakers, and Other Healthcare Stakeholders EDITORIAL Analyzing the Medtech Industry: A Predictive Tool in Healthcare David B. Nash, MD, MBA BUSINESS The Economic Burden of Fragile X Syndrome: Healthcare Resource Utilization in the United States ™ Patricia Sacco, MPH, RPh; Gorana Capkun-Niggli, PhD; Xin Zhang, MS; Rosemary Jose, PhD Stakeholder Perspective by Michael F. Murphy, MD, PhD A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk Heart Failure Patients Undergoing a Percutaneous Coronary Intervention David Gregory, MPA; Dennis J. Scotti, PhD, MBA; Gregory de Lissovoy, PhD, MPH; Igor Palacios, MD; Simon Dixon, MD; Brijeshwar Maini, MD; William O’Neill, MD Stakeholder Perspective by Raymond L. Singer, MD, MMM, CPE CLINICAL Effectiveness and Costs of TNF-Alpha Blocker Use for Patients with Rheumatoid Arthritis Kavita Nair, PhD; Vahram Ghushchyan, PhD; Ahmad Naim, MD Stakeholder Perspective by Michael S. Jacobs, RPh Industry Trends The Value of Actionable Content in a Clinical Setting: Access to Better Information Facilitates Enhanced Cancer Care Investing in Information Technology Pays Off: Meaningful Use Stage 1 Met by Majority of US Hospitals Opinion The Doctor Won’t See You Now: He’s Clocked Out ANNIVERSARY 6YEAR EST. 2008 ©2013 Engage Healthcare Communications, LLC

March/April 2013, Vol 6, No 2

Related publications